ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops drug therapies to treat eye diseases, announces acquisition of iScience Interventional Corp.’s patent portfolio covering drug delivery to the suprachoroidal space.
Uncategorized